China Resources Double-Crane Pharmaceutical Co Ltd

Common Name
CR Double-Crane
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
13,414
Ticker
600062
Exchange
SHANGHAI STOCK EXCHANGE
Description
China Resources Double Crane Pharmaceutical Co., Ltd. is a prominent player in the pharmaceutical industry, primarily engaged in the research, development, manufacturing, and distribution of a variety...

CR Double-Crane's GHG Emissions Data Preview

In 2023, CR Double-Crane completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

However, CR Double-Crane has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
0000000
Download Data

Verified Sources Behind CR Double-Crane’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CR Double-Crane’s data sources below and access millions more through our Disclosure Search.

a. CR Double-Crane's Sustainability Report 2023
a. CR Double-Crane's Sustainability Report 2023

Insights into CR Double-Crane's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of CR Double-Crane amounted to 243,121.81 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of CR Double-Crane decreased by 1.07%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

CR Double-Crane's Scope 1 Emissions Over Time

202120222023015 k30 k45 k60 ktCO2e-6%+8%
  • Total Scope 1
  • Year-over-Year Change

What are CR Double-Crane's Scope 1 emissions?

In 2023, the total Scope 1 emissions of CR Double-Crane were 51,608.37 metric tons of CO₂ equivalent (tCO₂e). a

Has CR Double-Crane reduced its Scope 1 emissions over time?

Since 2021, CR Double-Crane's Scope 1 emissions have increased by 1.89%, reflecting a rising long-term trend in Scope 1 emissions over time. a

Compared to the previous year (2022), CR Double-Crane's Scope 1 emissions increased by 8.26%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are CR Double-Crane's Scope 2 emissions?

In 2023, CR Double-Crane reported Scope 2 greenhouse gas (GHG) emissions of 191,513.44 tCO₂e without specifying the calculation method. a

Has CR Double-Crane reduced its Scope 2 emissions over time?

Since 2021, CR Double-Crane's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that CR Double-Crane 's emissions have plateaued with no significant change in its energy consumption footprint. a

Compared to the previous year (2022), CR Double-Crane's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CR Double-Crane 's emissions have plateaued with no significant change in its energy consumption footprint. a

What methodology does CR Double-Crane use for Scope 2 reporting?

In 2023, CR Double-Crane reported its Scope 2 emissions using an unspecified methodology. a

CR Double-Crane's Scope 2 Emissions Over Time

202120222023050 k100 k150 k200 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into CR Double-Crane's Value Chain Emissions

In 2023, CR Double-Crane reported 0 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2023 disclosure of CR Double-Crane includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2022, demonstrating consistent Scope 3 emissions reporting coverage year over year. a

CR Double-Crane's Scope 3 Emissions Over Time

20212022202301234tCO2eNaN%NaN%
  • Total Scope 3
  • Year-over-Year Change

What are CR Double-Crane's Scope 3 emissions?

In 2023, CR Double-Crane reported total Scope 3 emissions of 0 metric tons of CO₂ equivalent (tCO₂e). a

Insights into CR Double-Crane’s GHG Emissions Intensity Compared to Industry Peers

In 2023, CR Double-Crane reported Scope 1 greenhouse gas (GHG) emissions of 51,608.37 tCO₂e and total revenues of USD 1,438 millions. This translates into an emissions intensity of 35.88 tCO₂e per millions USD. a

CR Double-Crane's Scope 1 Emissions Intensity Compared to Peers

1020010,000200,00010,000,000Scope 1 Emissions (tCO2e)5502002,00010,000Revenues (Millions of USD)CHPDSDCCCanSino BiologicsYear: 2023Scope 1: 3,541 tCO2eRevenue: $M 49Scope 1 Intensity: 72.91 tCO2e/$MSimcere Pharmaceutical GroupYear: 2023Scope 1: 4,997 tCO2eRevenue: $M 1,017Scope 1 Intensity: 4.91 tCO2e/$MWalvax BiotechnologyYear: 2024Scope 1: 7,643 tCO2eRevenue: $M 387Scope 1 Intensity: 19.77 tCO2e/$MHumanwell Healthcare GroupYear: 2023Scope 1: 23,403 tCO2eRevenue: $M 3,451Scope 1 Intensity: 6.78 tCO2e/$MLuye Pharma GroupYear: 2023Scope 1: 10,755 tCO2eRevenue: $M 945Scope 1 Intensity: 11.38 tCO2e/$MLivzon Pharmaceutical GroupYear: 2024Scope 1: 194,441 tCO2eRevenue: $M 1,619Scope 1 Intensity: 120.13 tCO2e/$MCCChangchun High-TechYear: 2023Scope 1: 61,590 tCO2eRevenue: $M 2,050Scope 1 Intensity: 30.05 tCO2e/$MHansoh Pharmaceutical GroupYear: 2024Scope 1: 13,163 tCO2eRevenue: $M 1,830Scope 1 Intensity: 7.19 tCO2e/$MHHHuadong MedicineYear: 2023Scope 1: 14,289 tCO2eRevenue: $M 5,716Scope 1 Intensity: 2.50 tCO2e/$MJoincareYear: 2024Scope 1: 197,854 tCO2eRevenue: $M 2,140Scope 1 Intensity: 92.45 tCO2e/$MPPPorton Pharma SolutionsYear: 2024Scope 1: 18,865 tCO2eRevenue: $M 413Scope 1 Intensity: 45.71 tCO2e/$MBioKangtaiYear: 2023Scope 1: 15,952 tCO2eRevenue: $M 489Scope 1 Intensity: 32.60 tCO2e/$MZhejiang Jiuzhou PharmaceuticalYear: 2023Scope 1: 48,815 tCO2eRevenue: $M 777Scope 1 Intensity: 62.81 tCO2e/$MYunnan Baiyao GroupYear: 2023Scope 1: 28,983 tCO2eRevenue: $M 5,503Scope 1 Intensity: 5.27 tCO2e/$MConsun Pharmaceutical GroupYear: 2023Scope 1: 54,210 tCO2eRevenue: $M 398Scope 1 Intensity: 136.27 tCO2e/$MWeigao GroupYear: 2024Scope 1: 3,096 tCO2eRevenue: $M 1,952Scope 1 Intensity: 1.59 tCO2e/$MDDDong-E-E-JiaoYear: 2023Scope 1: 15,659 tCO2eRevenue: $M 663Scope 1 Intensity: 23.60 tCO2e/$MFosun PharmaYear: 2024Scope 1: 184,016 tCO2eRevenue: $M 5,627Scope 1 Intensity: 32.70 tCO2e/$MSSSihuan PharmaceuticalYear: 2023Scope 1: 45,602 tCO2eRevenue: $M 286Scope 1 Intensity: 159.27 tCO2e/$MTasly Pharmaceutical GroupYear: 2024Scope 1: 37,370 tCO2eRevenue: $M 1,164Scope 1 Intensity: 32.09 tCO2e/$MSichuan Kelun PharmaceuticalYear: 2024Scope 1: 2,361,763 tCO2eRevenue: $M 2,989Scope 1 Intensity: 790.21 tCO2e/$MHua MedicineYear: 2023Scope 1: 19 tCO2eRevenue: $M 12Scope 1 Intensity: 1.63 tCO2e/$MHepalinkYear: 2024Scope 1: 18,284 tCO2eRevenue: $M 724Scope 1 Intensity: 25.27 tCO2e/$MDDDa Ren TangYear: 2023Scope 1: 5,902 tCO2eRevenue: $M 1,157Scope 1 Intensity: 5.10 tCO2e/$MCCChina Resources SanjiuYear: 2024Scope 1: 55,312 tCO2eRevenue: $M 3,784Scope 1 Intensity: 14.62 tCO2e/$MCCCR Double-CraneYear: 2023Scope 1: 51,608 tCO2eRevenue: $M 1,438Scope 1 Intensity: 35.88 tCO2e/$M

How does CR Double-Crane's GHG emissions intensity compare to its peers?

In 2023, CR Double-Crane reported a Scope 1 emissions intensity of 35.88 tCO₂e per millions USD. Compared to the peer group median of 25.27 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does CR Double-Crane rank on GHG emissions intensity within its industry?

In 2023, CR Double-Crane ranked 18 out of 25 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

CR Double-Crane is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Insights into CR Double-Crane's Total Carbon Footprint

In 2023, CR Double-Crane reported a total carbon footprint of 243,121.81 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 1.07% decrease compared to 2022, indicating progress in reducing its overall greenhouse gas output. a

The largest contributor to CR Double-Crane's total carbon footprint was Scope 2 emissions, accounting for 78.77% of the company's total carbon footprint, followed by Scope 1 emissions at 21.23%. a

Want Full Access to CR Double-Crane's GHG Emissions Dataset?
Sign Up